86 results
Page 2 of 5
8-K/A
EX-99.1
6pxou mqaza
5 Aug 22
Vaxart Stockholders Approve Proxy Proposals 2, 3 and 4
8:02am
DEFA14A
ky9uid02ia fvp
1 Jul 22
Additional proxy soliciting materials
5:28pm
DEFA14A
qa592u
1 Jul 22
Additional proxy soliciting materials
12:32pm
8-K
EX-99.1
56tb 2qm1
16 Jun 22
Management to discuss progress on its programs, annual stockholders’ meeting proposals
4:06pm
8-K
EX-99.1
oxegd4
8 Jun 22
Vaxart Announces Adjournment of Annual Meeting of Stockholders
4:06pm
8-K
EX-99.1
u4l21gxfnhcwe oypk
9 May 22
Vaxart Provides Business Update and Reports First Quarter 2022 Financial Results
5:51pm
8-K
EX-99.1
zvbnn1d vj5
24 Feb 22
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:14pm
8-K
EX-99.1
1y5ze 64397yi8xvez
15 Feb 22
Vaxart Appoints Edward Berg as Senior Vice President and General Counsel
4:02pm
8-K
EX-99.1
elsuac2y7 b37s4dy
1 Dec 21
Vaxart Announces Acquisition of Second GMP Manufacturing Facility
4:00pm
8-K
EX-99.1
46rw3zxh16gm
4 Nov 21
Vaxart Provides Business Update and Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
llsdff7xxe
23 Aug 21
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
4:23pm
8-K
EX-99.1
zy95vdi exu0tb2v5c7
5 Aug 21
Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results
4:08pm
8-K
j0c0n y34hq91ugvfvqg
2 Aug 21
Results of Operations and Financial Condition
4:11pm
8-K
EX-99.1
v5llotqk
9 Jul 21
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset
4:02pm
8-K
6h60l41c3 ur1
3 May 21
Other Events
1:23pm
8-K
EX-99.1
2pou9a2r2jn v6hyvnq
25 Feb 21
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:04pm
8-K
EX-99.1
h4q5hn
3 Feb 21
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate
8:36am
8-K
EX-99.1
tpsfh2kf8c 4iaky1uz
12 Nov 20
Vaxart Reports Third Quarter 2020 Financial Results and Provides Business Update
4:03pm